Eltrombopag Phase III Study In Chinese Chronic ITP Patients
Clinical trial NCT01762761 · COMPLETED
Trial details
- NCT number
- NCT01762761
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-18
- Primary completion
- 2014-06-05
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.